Skip to main content
SpringerLink
Log in

Transurethral Microwave Therapy

  • Chapter
  • First Online:
Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate

  • 1335 Accesses

Abstract

Transurethral microwave thermotherapy (TUMT) was introduced as an office-based procedure commonly taking between 30 and 60 min. Postoperative catheterization times range from a few days to several weeks. TUMT uses radiant heating to ablate prostate tissue, where a microwave generator delivers energy to heat the prostate between 45°°C and 55 °C, causing necrosis. Over the last decade, high-energy TUMT has been revived as an attractive alternative to standard prostatectomy and TURP. A recent systematic review of the literature concluded that TUMT is an effective alternative to TURP. Multiple studies have demonstrated that various modalities of TUMT have short- and long-term improvement in subjective score measures and quantitative parameters such as Qmax.

TUMT has established itself as a safe and effective alternative to TURP. This procedure is continually evolving toward delivering better outcomes that are more tolerable to the patient and are more likely to be done in the outpatient setting by the urologist. A relatively low rate of morbidity and the absence of anesthesia from the treatment protocol make TUMT a true outpatient procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yerushalmi A, et al. Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol. 1985;133(5):873–6.

    PubMed  CAS  Google Scholar 

  2. McVary KT, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803.

    Article  PubMed  Google Scholar 

  3. Hoffman RM, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;9, CD004135.

    PubMed  Google Scholar 

  4. de la Rosette JJ, et al. EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol. 2001;40(3):256–63; discussion 264.

    Article  PubMed  Google Scholar 

  5. Madersbacher S, et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004;46(5):547–54.

    Article  PubMed  Google Scholar 

  6. Yu X, et al. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol. 2008;180(1):241–5; discussion 245.

    Article  PubMed  Google Scholar 

  7. Malaeb BS, et al. National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000–2008). Urology. 2012;79(5):1111–6.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Laguna MP, Muschter R, Debruyne FM. Microwave thermotherapy: historical overview. J Endourol. 2000;14(8):603–9.

    Article  PubMed  CAS  Google Scholar 

  9. Walmsley K, Kaplan SA. Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype. J Urol. 2004;172(4 Pt 1):1249–55.

    Article  PubMed  Google Scholar 

  10. Abbou CC, et al. Transrectal and transurethral hyperthermia versus sham treatment in benign prostatic hyperplasia: a double-blind randomized multicentre clinical trial. The French BPH hyperthermia. Br J Urol. 1995;76(5):619–24.

    Article  PubMed  CAS  Google Scholar 

  11. Le May C. First Canadian clinical study of transurethral hyperthermia in benign prostatic hyperplasia. Assessment of 220 patients. Eur Urol. 1992;21(3):184–6.

    PubMed  Google Scholar 

  12. Wagrell L, et al. Aspects on transurethral microwave thermotherapy of benign prostatic hyperplasia. Tech Urol. 2000;6(4):251–5.

    PubMed  CAS  Google Scholar 

  13. Bhowmick S, Swanlund DJ, Bischof JC. Supraphysiological thermal injury in Dunning AT-1 prostate tumor cells. J Biomech Eng. 2000;122(1):51–9.

    Article  PubMed  CAS  Google Scholar 

  14. Bhowmick S, et al. Evaluation of thermal therapy in a prostate cancer model using a wet electrode radiofrequency probe. J Endourol. 2001;15(6):629–40.

    Article  PubMed  CAS  Google Scholar 

  15. Bolmsjo M, et al. Cell-kill modeling of microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol. 2000;14(8):627–35.

    Article  PubMed  CAS  Google Scholar 

  16. Corvin S, et al. Effect of heat exposure on viability and contractility of cultured prostatic stromal cells. Eur Urol. 2000;37(4):499–504.

    Article  PubMed  CAS  Google Scholar 

  17. Brehmer M, Baba S. Transurethral microwave thermotherapy: how does it work? J Endourol. 2000;14(8):611–5.

    Article  PubMed  CAS  Google Scholar 

  18. de la Rosette JJ, D’Ancona FC, Debruyne FM. Current status of thermotherapy of the prostate. J Urol. 1997;157(2):430–8.

    Article  PubMed  Google Scholar 

  19. Brehmer M, Hilliges M, Kinn AC. Denervation of periurethral prostatic tissue by transurethral microwave thermotherapy. Scand J Urol Nephrol. 2000;34(1):42–5.

    Article  PubMed  CAS  Google Scholar 

  20. Brehmer M, Nilsson BY. Elevation of sensory thresholds in the prostatic urethra after microwave thermotherapy. BJU Int. 2000;86(4):427–31.

    Article  PubMed  CAS  Google Scholar 

  21. Bolmsjo MB, Vrba T. Microwave applicators for thermotherapy of benign prostatic hyperplasia: a primer. Tech Urol. 2000;6(4):245–50.

    PubMed  CAS  Google Scholar 

  22. Brehmer M. Morphological changes in prostatic adenomas after transurethral microwave thermotherapy. Br J Urol. 1997;80(1):123–7.

    Article  PubMed  CAS  Google Scholar 

  23. Brehmer M, Svensson I. Heat-induced apoptosis in human prostatic stromal cells. BJU Int. 2000;85(4):535–41.

    Article  PubMed  CAS  Google Scholar 

  24. Devonec M, et al. Clinical response to transurethral microwave thermotherapy is thermal dose dependent. Eur Urol. 1993;23(2):267–74.

    PubMed  CAS  Google Scholar 

  25. Bolmsjo M, et al. The heat is on–but how? A comparison of TUMT devices. Br J Urol. 1996;78(4):564–72.

    Article  PubMed  CAS  Google Scholar 

  26. Miller PD, et al. Cooled thermotherapy for the treatment of benign prostatic hyperplasia: durability of results obtained with the Targis system. Urology. 2003;61(6):1160–4; discussion 1164–5.

    Article  PubMed  Google Scholar 

  27. Kaplan SA, Blute M, Bruskewitz RC, Larson TR, Utz W, Ugarte R, Mayer R. Long term efficacy and durability in 345 patients treated with transurethral microwave thermotherapy for benign prostatic hyperplasia: five year results. J Urol. 2002;167(Suppl):297.

    Google Scholar 

  28. Berger AP, et al. Transurethral microwave thermotherapy (TUMT) with the Targis system: a single-centre study on 78 patients with acute urinary retention and poor general health. Eur Urol. 2003;43(2):176–80.

    Article  PubMed  Google Scholar 

  29. Thalmann GN, et al. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results. J Urol. 2002;167(6):2496–501.

    Article  PubMed  Google Scholar 

  30. Huidobro C, Cabezas J, Cote E, Mynderse L, Partin A, Preminger G. Results of a new advancement in high temperature cooled thermotherapy (TUMT) for benign prostatic hyperplasia (BPH). J Urol. 2003;169(Suppl):390.

    Google Scholar 

  31. D’Ancona FC, et al. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol. 1998;81(2):259–64.

    Article  PubMed  Google Scholar 

  32. Albala DM, Andriole G, Davis BE, Eure GR, Kabalin JN, Lingeman JE. Transurethral microwave thermotherapy (TUMT) using the Thermatrx TMX-2000: durability exhibited in a study comparing TUMT with a Sham procedure in patients with benign prostatic hyperplasia (BPH). J Urol. 2003;169(Suppl):465.

    Google Scholar 

  33. Francisca EA, et al. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol. 1999;161(2):486–90.

    Article  PubMed  CAS  Google Scholar 

  34. Floratos DL, et al. Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol. 2001;165(5):1533–8.

    Article  PubMed  CAS  Google Scholar 

  35. Selvaggio O, Ditonno P, Battaglia M, Bettocchi C, Saracino A, Palazzo S. Long term results (4 years) of high-energy transurethral microwave. Eur Urol. 2003;2:102.

    Google Scholar 

  36. Laguna P, van Hest P, Smelov V, Gravas S, Kiemeney B, de la Rosette JJ. Efficacy and durability of the 30 minutes high energy TUMT protocol in 213 patients. J Endourol. 2002;15(Suppl):38.

    Google Scholar 

  37. Mattiasson A, et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology. 2007;69(1):91–6; discussion 96–7.

    Article  PubMed  Google Scholar 

  38. Mynderse LA, et al. Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol. 2011;185(5):1804–10.

    Article  PubMed  Google Scholar 

  39. Albala DM, et al. Office-based transurethral microwave thermotherapy using the TherMatrx TMx-2000. J Endourol. 2002;16(1):57–61.

    Article  PubMed  Google Scholar 

  40. Wagrell L, et al. Feedback microwave thermotherapy versus TURP for clinical BPH–a randomized controlled multicenter study. Urology. 2002;60(2):292–9.

    Article  PubMed  Google Scholar 

  41. Laguna MP, et al. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol. 2002;167(4):1727–30.

    Article  PubMed  Google Scholar 

  42. Gravas S, Laguna MP, de la Rosette JJ. Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up. J Endourol. 2003;17(6):425–30.

    Article  PubMed  Google Scholar 

  43. Djavan B, et al. Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology. 2001;57(1):66–70.

    Article  PubMed  CAS  Google Scholar 

  44. Shore ND, Sethi PS. A controlled, randomized, head-to-head comparison of the Prolieve thermodilatation system versus the Targis system for benign prostatic hyperplasia: safety, procedural tolerability, and clinical results. J Endourol. 2010;24(9):1469–75.

    Article  PubMed  Google Scholar 

  45. Trachtenberg J, Roehrborn CG. Updated results of a randomized, double-blind, multicenter sham-controlled trial of microwave thermotherapy with the Dornier Urowave in patients with symptomatic benign prostatic hyperplasia. Urowave Investigators Group. World J Urol. 1998;16(2):102–8.

    Article  PubMed  CAS  Google Scholar 

  46. Larson TR, et al. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology. 1998;51(5):731–42.

    Article  PubMed  CAS  Google Scholar 

  47. Blute ML, et al. Transurethral microwave thermotherapy v sham treatment: double-blind randomized study. J Endourol. 1996;10(6):565–73.

    Article  PubMed  CAS  Google Scholar 

  48. Francisca EA, et al. Quality of life assessment in patients treated with lower energy thermotherapy (Prostasoft 2.0): results of a randomized transurethral microwave thermotherapy versus sham study. J Urol. 1997;158(5):1839–44.

    Article  PubMed  CAS  Google Scholar 

  49. Nawrocki JD, et al. A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol. 1997;79(3):389–93.

    Article  PubMed  CAS  Google Scholar 

  50. Trock BJ, et al. Long-term pooled analysis of multicenter studies of cooled thermotherapy for benign prostatic hyperplasia results at three months through four years. Urology. 2004;63(4):716–21.

    Article  PubMed  Google Scholar 

  51. Aagaard MF, et al. Transurethral microwave thermotherapy treatment of chronic urinary retention in patients unsuitable for surgery. Scand J Urol. 2013;48:290–4.

    Article  PubMed  Google Scholar 

  52. Vesely S, et al. Transurethral microwave thermotherapy: clinical results after 11 years of use. J Endourol. 2005;19(6):730–3.

    Article  PubMed  Google Scholar 

  53. Tan AH, et al. Long-term results of microwave thermotherapy for symptomatic benign prostatic hyperplasia. J Endourol. 2005;19(10):1191–5.

    Article  PubMed  Google Scholar 

  54. Vesely S, et al. TURP and low-energy TUMT treatment in men with LUTS suggestive of bladder outlet obstruction selected by means of pressure-flow studies: 8-year follow-up. Neurourol Urodyn. 2006;25(7):770–5.

    Article  PubMed  Google Scholar 

  55. Nickel JC. BPH: costs and treatment outcomes. Am J Manag Care. 2006;12(5 Suppl):S141–8.

    PubMed  Google Scholar 

  56. Djavan B, Kazzazi A, Bostanci Y. Revival of thermotherapy for benign prostatic hyperplasia. Curr Opin Urol. 2012;22(1):16–21.

    Article  PubMed  Google Scholar 

  57. de la Rosette JJ, et al. Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia? J Endourol. 2003;17(4):245–51.

    Article  PubMed  Google Scholar 

  58. Norby B, Nielsen HV, Frimodt-Moller PC. Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int. 2002;90(9):853–62.

    Article  PubMed  CAS  Google Scholar 

  59. D’Ancona FC, et al. Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification. Urology. 1999;53(2):322–8.

    Article  PubMed  Google Scholar 

  60. D’Ancona FC, et al. High energy transurethral thermotherapy in the treatment of benign prostatic hyperplasia: criteria to predict treatment outcome. Prostate Cancer Prostatic Dis. 1999;2(2):98–105.

    Article  PubMed  Google Scholar 

  61. Djavan B, et al. Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature. Can J Urol. 2010;17(4):5249–54.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urology, Associated Medical Professionals of NY, Syracuse, NY, USA

    Ilija Aleksic M.D.

  2. Clinical Research, Urology, Associated Medical Professionals of NY, Syracuse, NY, USA

    Vladimir Mouraviev M.D.

  3. Urology, Associated Medical Professionals of NY/Crouse Hospital, 1226 E. Water St., Syracuse, NY, USA

    David M. Albala M.D.

Authors
  1. Ilija Aleksic M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vladimir Mouraviev M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David M. Albala M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David M. Albala M.D. .

Editor information

Editors and Affiliations

  1. Department of Urology, Weill Cornell Medical College, New York, New York, USA

    Bilal Chughtai

  2. Department of Urology, Weill Cornell Medical College, New York, New York, USA

    Alexis E. Te

  3. Department of Urology, Weill Cornell Medical College, New York, New York, USA

    Steven A. Kaplan

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Aleksic, I., Mouraviev, V., Albala, D.M. (2015). Transurethral Microwave Therapy. In: Chughtai, B., Te, A., Kaplan, S. (eds) Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1587-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1587-3_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1586-6

  • Online ISBN: 978-1-4939-1587-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation